Obimed Pharmaceutical Ltd.

Quality & Compliance

How we keep every API and food-grade raw material we supply compliant, traceable and fit for manufacturing.

QUALITY ASSURANCE & QUALITY CONTROL POLICY

Obimed Pharmaceuticals Limited

Control Element

Reference Information

Document Control Number

OPL/QA/SOP/001

Effective Date

October 2026

Review Date

October 2028

Entity

Obimed Pharmaceuticals Limited ("Obimed")

Scope

Raw Material Sourcing, Active Pharmaceutical Ingredients (APIs), Excipients, Food-Grade Additives, Storage, and B2B Distribution

1. Policy Statement & Purpose

Obimed Pharmaceuticals Limited is committed to delivering Active Pharmaceutical Ingredients (APIs), pharmaceutical excipients, and industrial food additives that consistently comply with international pharmacopeial standards (USP, BP, EP), local regulatory requirements (NAFDAC, PCN), and client specifications.

 

This Quality Assurance Policy establishes strict, audit-ready operational frameworks for vendor qualification, batch traceability, sampling, storage control, and Certificate of Analysis (COA) verification across all raw material procurement and supply chain cycles.

2. Vendor Qualification & Supplier Auditing

To guarantee supply integrity at the source, all international and local manufacturers supplying Obimed must undergo a mandatory Vendor Qualification Process prior to onboarding.

 

  • Audit Requirements: Suppliers must provide proof of Good Manufacturing Practice (GMP) certification issued by a recognized regulatory authority (e.g., US FDA, EMA, WHO-GMP, or equivalent local regulatory authority).
  • Documentary Due Diligence: Every vendor onboarding file must contain:
    • Manufacturer GMP and ISO certificates.
    • Site Master File (SMF) summary or Drug Master File (DMF) open parts where applicable.
    • Product Specification Sheets and Material Safety Data Sheets (MSDS).
    • Historical Certificate of Analysis (COA) batch records.
  • Periodic Re-Evaluation: Approved Suppliers are re-evaluated annually based on batch consistency, delivery compliance, COA accuracy, and audit track record.

3. Receiving, Inbound Inspection & Quarantine Protocol

All incoming consignments of raw materials (APIs, excipients, and food-grade chemicals) arriving at Obimed’s warehouses or client fulfillment centers must undergo strict inbound inspection.

Inbound Operational Workflow

  1. Inbound Shipment Arrival & Physical Inspection: Check seal integrity, labeling, container integrity, and batch match.
  2. Quarantine Area Placement: Upon offloading, materials are immediately placed in a designated, physically segregated Quarantine Area under "HOLD" status (Yellow Flag / Status Tag).
  3. QC Sampling & Testing: Quality Control (QC) officers perform sampling using representative statistical sampling techniques (e.g., $n = 1 + \sqrt{N}$ sampling plan) in accordance with pharmacopeial guidelines.
  4. COA Reconciliation: The manufacturer's batch Certificate of Analysis (COA) is cross-verified parameter-by-parameter against Obimed's internal acceptance standards and client specifications.
  5. Disposition: Approved materials receive a Green Tag for inventory release. Rejected materials receive a Red Tag and are moved to isolated quarantine.

4. Analytical Verification & Testing Standards

  • In-House & Retain Sampling: Retain samples from every imported batch are securely archived in the QA Retain Sample Vault for a minimum of 12 months beyond the product expiration date.
  • Third-Party Confirmatory Testing: For high-volume APIs and sensitive excipients, Obimed engages NAFDAC-accredited independent analytical testing laboratories to verify:
    • Identification & Assay Percentage (e.g., HPLC / Titration).
    • Impurity Profile & Residual Solvents.
    • Microbial Limit Testing (MLT) for food-grade and oral formulation raw materials.
    • Physical Properties: Particle size distribution, loss on drying (LOD), bulk/tapped density, and solubility.

5. Storage, Climate Control & Distribution QA

Obimed maintains warehouse conditions designed to protect chemical stability and prevent degradation or cross-contamination.

Storage Parameters

Parameter

Specification & Operational Standard

Monitoring Protocol

Ambient Storage

Controlled 15°C to 25°C (30°C max excursions)

Continuous digital logging & 2x daily manual audits

Cold Chain

2°C to 8°C refrigerated storage

Continuous automated alarm systems

Relative Humidity

Below 60% RH

Daily verification via calibrated hygrometer

Segregation

Physical separation by shipment intake

Separate area designation for Food-Grade vs. Pharma Grade

Distribution Framework

  • FEFO System: Materials are dispatched using a strict First Expired, First Out (FEFO) inventory management system to prevent shelf-life erosion.
  • Dispatch Documentation: Every outgoing client shipment is dispatched with an official, signed Obimed Quality Delivery Pack, containing:
    1. Batch-specific Certificate of Analysis (COA).
    2. Material Safety Data Sheet (MSDS).
    3. Quality Release Certificate signed by the Designated Qualified Person / QA Lead.

6. Out-of-Specification (OOS) & Customer Complaints Protocol

  • Out-of-Specification (OOS) Handling: Any batch failing analytical testing or visual inspection is immediately moved to the physically locked Rejected Materials Storage (tagged with Red Notice Signs). An OOS Investigation Report is opened within 24 hours to identify root causes.
  • Customer QA Complaints: Client complaints regarding raw material performance, particle size discrepancies, or packaging defects must be logged within 5 business days of delivery. Obimed QA initiates a joint investigation within 48 hours. If non-conformance is validated, Obimed coordinates immediate product recall, quarantine of affected lots, and replacement batch release at no extra cost to the client.

7. Change Control, Traceability & Audit Readiness

  • Batch Traceability: Obimed maintains complete batch traceability logs from port of entry to client manufacturing facility, ensuring any lot can be pinpointed and recalled within 24 hours.
  • Change Control: Any change in raw material manufacturing site, synthetic route, or packaging specification requires formal notification to downstream manufacturing clients prior to dispatch.
  • Annual QA Review: All QA/QC protocols are subjected to an annual management audit to maintain alignment with evolving NAFDAC guidelines, PCN regulations, and international standards.

Document Approval

Role

Entity / Department

Drafted By

Legal & Quality Assurance Compliance Team

Approved By

Management, Obimed Pharmaceuticals Limited

Distribution List

Quality Control Unit, Operations, Warehouse Logistics, and B2B Sales Desk